We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:AVLN
​
​
logo

Avalyn Pharma Inc. (AVLN)

Nasdaq • AVLN • US05348Y1055

29.15Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 9.4% of free float sold short, 7.4 days to cover, cost to borrow 1.87%. Sign up for live short interest data.

Market Cap

1.29b USD | # 4564 in US

Volume

311.76k shares | 9.64m USD

Shares Outstanding

44.33m

Free Float Shares

56.67% | 25.13m

News

AVLN key data

Avalyn Pharma Inc. (Nasdaq: AVLN) has a market capitalization of $1.29B. Last close $29.15 (as of 2026-11-09); 52-week range $22.24 to $40.17. ORTEX data as of 2026-10-22: short interest was 9.4% of free float, 7.4 days to cover and the average cost to borrow was 1.87%. Sign up for live short interest data.

  • AVLN news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.